البحث | Bundas24

Rahul Rangwa أضاف وظيفة جديدة أخرى
2025-07-14 06:52:03 -

GM1 Gangliosidosis Market Advances with Growing Focus on Rare Disease Research and Orphan Drug Development
"Executive Summary GM1 Gangliosidosis Market : The GM1 gangliosidosis market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 26.50% in the above mentioned research forecast period. The market study of GM1 Gangliosidosis Market report helps minimize the risks of uncertainties and...

0 التعليقات 0 المشاركات 451 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Sia Smith أضاف وظيفة جديدة أخرى
2025-07-17 08:51:25 -

Adrenoleukodystrophy Treatment Market Advances with Gene Therapy and Rare Disease Awareness
"Executive Summary Adrenoleukodystrophy Treatment Market : The adrenoleukodystrophy treatment market is expected to witness market growth at a rate of 10.25% in the forecast period of 2022 to 2029. This Adrenoleukodystrophy Treatment Market report is designed with the scrupulous market analysis carried out by a team of industry experts, dynamic analysts, skilful forecasters and...

0 التعليقات 0 المشاركات 701 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Sia Smith أضاف وظيفة جديدة أخرى
2025-07-15 09:35:33 -

Cystic Fibrosis Market Grows Globally with Breakthroughs in Genetic Therapy and Personalized Medicine
"Executive Summary Cystic Fibrosis Market : The cystic fibrosis market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 31.15% in the forecast period of 2021 to 2028. Cystic Fibrosis Market report is offered to the business with a complete overview of the market,...

0 التعليقات 0 المشاركات 579 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Sia Smith أضاف وظيفة جديدة Networking
2025-07-28 08:14:37 -

Global Scleroderma Drugs Market Advances with Novel Therapies and Clinical Trials
"Executive Summary Scleroderma Drugs Market : CAGR Value The global scleroderma drugs market size was valued at USD 1.48 billion in 2024 and is projected to reach USD 2.97 billion by 2032, with a CAGR of 9.20% during the forecast period of 2025 to 2032. The Scleroderma Drugs Market report is a synopsis about how is the market status right now and how will it be in the...

0 التعليقات 0 المشاركات 533 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!